Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 AUD | -1.64% |
|
-11.76% | +71.43% |
02:16am | Cleo Diagnostics Secures US FDA Feedback for Ovarian Cancer Test | MT |
06-23 | 7,500,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 23-JUN-2024. | CI |
- Stock Market
- Equities
- COV Stock
- News Cleo Diagnostics Ltd
- MarketScreener Editorial Features